Table 2.
Patient characteristics. HCC: hepatocellular carcinoma; CCC: cholangiocellular carcinoma
| HCC | CCC | All tumors | |
|---|---|---|---|
| Total no. | 71 | 27 | 98 |
| Sex | |||
| male | 57 | 23 | 80 |
| female | 14 | 4 | 18 |
| Age (years) | |||
| mean | 63.9 | 65.5 | 64.4 |
| median | 65.0 | 66.0 | 65 |
| Survival (months) | |||
| mean | 20.3 | 14.7 | 18.8 |
| median | 18.0 | 11.0 | 15.0 |
| Stage (n) | |||
| I | 24 [34%] | 8 [30%] | 32 [33%] |
| II | 20 [28%] | 13 [48%] | 33 [34%] |
| IIIA | 18 [26%] | 1 [4%] | 19 [19%] |
| IIIB | 0 [0%] | 0 [0%] | 0 [0%] |
| IIIC | 1 [1%] | 0 [0%] | 1 [1%] |
| IVA | 0 [0%] | 3 [11%] | 3 [3%] |
| IVB | 8 [11%] | 2 [7%] | 10 [10%] |
| Grading (n) | |||
| G1 | 13 [18%] | 1 [4%] | 14 [14%] |
| G2 | 43 [61%] | 18 [66%] | 61 [62%] |
| G3 | 15 [21%] | 7 [26%] | 22 [23%] |
| G4 | 0 [0%] | 1 [4%] | 1 [1%] |